


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-0.13%
+31.37%
+8.62%
-2.81%
IRWD
Ironwood Pharma
$4.04
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Outperform the market
IRWD Price Performance
$3.69 (+9.49%)
$1.48 (+172.97%)
$1.03 (+292.23%)
$1.03 (+292.23%)
IRWD has Fair risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Price under $5

High volatilty

IRWD overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Earnings increase YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
IRWD Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
IRWD Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
What is IRWD current stock price?
What are IRWD stock strengths?
What is IRWD Risk Level?
What is IRWD market cap and volume?
What is IRWD current Stock IQ?
Should I buy IRWD stock right now?
Is IRWD a Strong Buy right now?
What does a 'Strong Buy' rating mean for IRWD?
What does a 'Strong Sell' rating mean for IRWD?
What factors influence IRWD's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-0.13%
+31.37%
+8.62%
-2.81%
IRWD
Ironwood Pharma
Current Price
$4.04
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Outperform the market

IRWD Price Performance
$3.69 (+9.49%)
$1.48 (+172.97%)
$1.03 (+292.23%)
$1.03 (+292.23%)
IRWD Analysts Opinion
IRWD Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Earnings increase YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
IRWD Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
IRWD Street Sentiment is extremely bullish and have positive views on the near-term outlook
IRWD has Fair risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Price under $5

High volatilty

Average key support and resistance price levels
IRWD Stock IQ
IRWD Latest Analysis
Nuveen Green Capital and Lone Star PACE Facilitate $21.9 Million C-PACE Transaction for New Multifamily Development North of Dallas. DALLAS Jan. 06 2026 (GLOBE NEWSWIRE) -- Nuveen Green Capital a leader in sustainable commercial real estate financing solutions in conjunction with Lone Star PACE a leading administrator of Texas'. C-PACE programs has facilitated $21.9 million in C-PACE financing for Ironwood at Princeton. This new Class-A multifamily community is planned for 599 W. Princeton D
Tue Jan 6, 2026
Citizens Upgrades Ironwood Pharmaceuticals (IRWD). Fintel reports that on January 5 2026 Citizens upgraded their outlook for Ironwood Pharmaceuticals (NasdaqGS:IRWD) from Market Perform to Market Outperform. Analyst Price Forecast Suggests 44.44% Downside
Tue Jan 6, 2026
Ironwood Stock Rises 27% on Upbeat Revenue Guidance for 2026. IRWD shares jump on upbeat 2026 revenue guidance amid rising Linzess demand in the United States. The company also provides a key pipeline update.
Mon Jan 5, 2026
Citizens upgrades Ironwood Pharmaceuticals stock rating on LINZESS strength.
Mon Jan 5, 2026
Ironwood Reaffirms FY2025 Revenue Outlook Sees Growth In FY2026. Stock Surges . (RTTNews) - Ironwood Pharmaceuticals (IRWD) a commercial-stage biotechnology company today provided guidance for fiscal year 2026 while reaffirming its 2025 outlook sending the shares to a new 52-week high of $5.58.
Fri Jan 2, 2026
Why Intelligent Bio Solutions Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Fridays Mid-Day Session. Shares of INBS) fell sharply during Friday'.s session after the company announced plans to raise fresh capital.Intelligent Bio said it will raise $10 million through a private placement which weighed on shares following the announcement.Intelligent Bio Solutions shares dipped 19.7% to $7.65 on Friday.Here are some other stocks moving in today’.s mid-day session.
Fri Jan 2, 2026
Ironwood Pharma Stock Rallies On Strong 2026 Outlook. IRWD) stock rose Friday with a session volume of 38.35 million compared to the average volume of 2.36 million as per .The gastrointestinal-focused biotechnology company released financial guidance for the .Ironwood expects 2026 Linzess US net sales of $1.125 billion-$1.175 billion with total revenue expectation of $450 million-$475 million.Also Read: The company expects 2026 adjusted EBITDA of over $300 million.Ironwood reaffirmed 2025 Linzes
Fri Jan 2, 2026
Ironwood Pharmaceuticals Baidu Vertiv Holdings And Other Big Stocks Moving Higher On Friday. United States stocks were higher with the Nasdaq Composite gaining more than 1% on Friday.Shares of IRWD) rose sharply during Friday'.s session after the Ironwood expects 2026 Linzess US net sales of $1.125 billion-$1.175 billion with total revenue expectation of $450 million-$475 million. The company expects 2026 adjusted EBITDA of over $300 million.Ironwood Pharmaceuticals shares jumped 57.7% to $5
Fri Jan 2, 2026
Ironwood rises after settling Ferring lawsuit.
Tue Dec 23, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
IRWD Stock trends
IRWD Stock performance
IRWD Stock analysis
IRWD investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.